91¹ú²ú¾«Æ·

Stage four lymphoma diagnosis most common in children and young adults newly enrolled in Medicaid (WASHINGTON, November 12, 2024) – Continuous enrollment in Medicaid was associated with a lower rate of a late-stage lymphoma diagnosis in children and...

Dr. Kleinerman to be recognized at the 2024 ASH Annual Meeting for decades of dedicated service to advancing hematology   (WASHINGTON – November 8, 2024) — The 91¹ú²ú¾«Æ· (ASH) will recognize Judith Kleinerman, MD, as the rec...

Five-year term of Dr. Andrew Roberts to begin in January 2025 (WASHINGTON, Oct. 31, 2024) — The 91¹ú²ú¾«Æ· (ASH) has selected Andrew Roberts, MBBS, PhD, clinical hematologist at the Royal Melbourne Hospital and Peter MacCallum Ca...

(WASHINGTON, October 28, 2024) – The 91¹ú²ú¾«Æ· (ASH), the world’s largest professional society focused on advancing the field of blood disorders, announced the election of four new members to its Executive Committee f...

Drs. Willem Fibbe and Patrick Gallagher selected to head new specialty hematology publications (WASHINGTON, Oct. 9, 2024) — The 91¹ú²ú¾«Æ· (ASH) has selected Willem Fibbe, MD, and Patrick Gallagher, MD, to serve as the inau...

Social factors significantly affected patient health despite wrap-around care (WASHINGTON – October 7, 2024) - A new study finds that preschool-aged children with sickle cell disease (SCD) who live in food deserts and have limited access to transpo...

Study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma (WASHINGTON – October 4, 2024) In the first study to report real-world outco...

Study of liso-cel in patients with relapsed or refractory large B-cell lymphoma points to the benefits of bringing advanced therapies closer to patients, minimizing hospitalizations (WASHINGTON – September 30, 2024) In the largest prospective study...

Research priorities will help direct the field and deliver progress for the next five years (WASHINGTON, September 25, 2024) — The 91¹ú²ú¾«Æ· (ASH) has released new comprehensive sickle cell disease (SCD) research prioritie...

Rising stroke rates indicate need for greater adherence to standard of care and attention to modifiable risk factors (WASHINGTON, September 20, 2024) –The incidence of stroke continues to increase for adults and children living with sickle cell...